Diageoの空売り状況は、投資家がDiageoの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Diageo (NYSE:DEO) 株価情報, 空売り情報

Diageo

Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.

Diageo PLC

Deoleo SA

Shares of major alcohol producers and distributors declined sharply Friday following a warning issued by U.S. Surgeon General Vivek Murthy about the increased cancer risks <a href="https://www.benzinga.com/government/regulations/25/01/42787400/alcohol-increases-cancer-risk-surgeon-general-warns">associated with alcohol consumption.</a>
What To Know: Murthy&#8217;s advisory emphasized the need for updated health warning labels to reflect mounting evidence of alcohol&#8217;s connection to cancer. These labels have not been revised since 1988. The advisory also called for reassessing recommended alcohol consumption limits, highlighting alcohol's role as the third-leading preventable cause of cancer in the United States, behind tobacco and obesity.
Murthy&#8217;s statement drew attention to alcohol&#8217;s association with at least seven types of cancer, including breast, liver and colorectal cancers. He pointed out that alcohol consumption contributes to approximately 100,000 cancer cases and 20,000 deaths annually in the United States. The announcement highlighted that only 45% of American adults are aware of the cancer risks posed by alcohol.
Stocks of leading alcohol companies reacted negatively to the news. 
Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) saw its shares drop by 3.72%, while Boston Beer Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4.26%. Anheuser-Busch InBev Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>)&#8217;s stock declined by 1.84% and Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) saw a 1.5% decrease. Diageo Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) stock also traded lower, falling 3.15%. Brown-Forman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>), the maker of Jack Daniel&#8217;s whiskey, experienced a 2.58% decline.
The Surgeon General's advisory reignited discussions about public health measures and the potential for new regulations requiring updated warning labels on alcohol products. 
Price Action: Molson Coors shares were down 3.25% at $55.27, Boston Beer shares were down 3% at $292.60 and Anheuser-Busch shares were down 1.85% at $49 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro.</a>
Image Via Shutterstock.

News

Movers

Alcohol Stocks Are Falling Today: What's Going On?

WIIM

Fomento Economico Mexicano S.A.B. De C.V.

Shares of alcohol stocks are trading lower after US Surgeon General Murthy issued an advisory warning alcohol consumption could raise cancer risk.

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Friday.
Shares of United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) fell sharply in <a href="https://www.benzinga.com/markets/equities/25/01/42779827/joe-biden-to-decide-on-nippon-steels-14-9b-us-steel-acquisition-on-friday-amid-veto-offer-labor-concerns">today's pre-market trading</a>.
This decline comes as President Joe Biden is poised to block the proposed acquisition by Nippon Steel (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NPSCY#OTC">NPSCY</a>), potentially as soon as Friday, Reuters reported, citing a source familiar with the matter.
United States Steel shares dipped 7.3% to $30.23 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Tejon Ranch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRC#NYSE">TRC</a>) shares dipped 11.4% to $14.01 in pre-market trading.</li>
<li>Lincoln Educational Services Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) shares fell 7.7% to $14.10 in pre-market trading after falling over 3% on Thursday.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) fell 4.6% to $15.39 in pre-market trading after jumping over 16% on Thursday.</li>
<li>Enhabit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) fell 4.5% to $7.40 in pre-market trading.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 2.9% to $122.58 in pre-market trading.</li>
<li>Nabors Energy Transition Corp. II (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NETD#NASDAQ">NETD</a>) fell 2.8% to $10.51 in pre-market trading.</li>
<li>Metallus Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTUS#NYSE">MTUS</a>) 2.8% to $13.31 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42763645/how-to-earn-500-a-month-from-acuity-brands-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

EHAB

HSAI

LINC

MTUS

NETD

NPSCY

United States Steel, Diageo And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Macro Economic Events

Politics

Economics

General

Reuters Reported Trump's Mexican Tariff Plan Could Hit U.S. Tequila Imports From Diageo, Becle Worth $3+B Combined In 2023

Donald Trump&#8216;s 2024 presidential election win put several sectors in the spotlight, <a href="https://www.benzinga.com/topic/alcohol">including alcohol stocks.</a>
What Happened: Some people watched the outcome of <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">election night</a> on television from their home. Others likely scrolled along with social media on their phone. Some attended watch parties with friends and families, similar to a Super Bowl party or one for <a href="https://www.benzinga.com/top-stories/24/08/40610039/are-nvidia-earnings-wall-streets-super-bowl-super-bulls-arrange-watch-parties-in-new-york-city">Nvidia's quarterly earnings.</a> 
Regardless of who voters wanted to win — Trump or Kamala Harris — they may have bought more alcohol for Election Day this year, at least in New York, with liquor stores reporting a busy day.
One liquor store <a href="https://nypost.com/2024/11/06/us-news/nyc-liquor-stores-were-crazy-busy-on-election-night-workers-say-weve-been-spending-hours-just-restocking/">told </a>the New York Post they were three to four times busier than a regular weekday on Election Day with heavy sales coming in the early afternoon and around 5 p.m. ET. An employee from Brooklyn's Juice Box liquor store told the Post there was also a noticeable trend from many customers.
"People were buying sparkling wine and a bottle of liquor for both (outcomes)," the employee said.
Employees from other New York stores noticed the same trend. Customers were either buying one type of alcohol for a happy outcome or one for a negative outcome.
"I have no idea if people will be drowning their sorrows or celebrating," the Juice Box employee added.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: While it is only one day of the year, Election Day 2024 could provide a short bump for alcohol stocks like Diageo Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) and Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>). Beer stocks like Anheuser-Busch InBev (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>), Boston Beer Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) and Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) may have also benefitted from Election Day.
Alcohol may be a coping or celebratory item for Election Day in the U.S., but in India the country <a href="https://timesofindia.indiatimes.com/world/us/us-election-2024-does-america-have-dry-days-like-india-during-election-season/articleshow/114945854.cms">has </a>dry days of no alcohol around their elections with residents unable to drink for 48 hours before the vote, on election day or as the vote is being totaled.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41817245/will-trump-be-sentenced-in-hush-money-trial-or-will-his-criminal-problems-go-away">Will Trump Be Sentenced In Hush Money Trial Or Will His &#8216;Criminal Problems Go Away&#8217;?</a></li>
</ul>
Image: Shutterstock

Alcohol Stocks To Get A Boost From 2024 Election? Busy Liquor Stores Say Voters 'Drowning Their Sorrows Or Celebrating'

<ul>
<li>Nikola trucks to be the first Class 8 hydrogen fuel cell electric vehicles operated day-to-day in the state of Illinois</li>
</ul>

NKLA

DHL Supply Chain And Diageo To Incorporate Two Fuel Cell Electric Trucks; Class 8 Trucks Manufactured By Nikola Will Be Deployed With HYLA Modular Refueler At Diago Campus

Constellation Brands (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stz#NYSE">STZ</a>) issued a mixed August quarter results lasy week, posting better than expected earnings as it continues to navigate a tough market.
<h3>Highlights Of The Second Quarter Of Fiscal 2025</h3>
Fueled by strong demand for its beer brands, especially Corona and Modelo, Constellation&nbsp;Brands reported net sales grew by 3% YoY to $2.92 billion.
Sales revenues increased by 6%&nbsp;while shipments&nbsp;grew by 4.6%.
Having already issued an alarm for its declining wines and spirits business whose sales dropped 12% to&nbsp;$388.7 million, Constellation reported a $2.5 billion write down. Wine and spirits were dragged down by a&nbsp;9.8% drop in shipment volumes.&nbsp;The division&rsquo;s operating income contracted 13% YoY to&nbsp;$70.5 million.
For the quarter ended on August 31st,&nbsp;adjusted earnings per share amounted to $4.32, surpassing&nbsp;LSEG&rsquo;s average estimate of $4.08.
Constellation can rely on its beer brands.
Beers have been the driver of Constellations&rsquo; success even before the pandemic lockdowns. Even in the post-pandemic era, consumers are turning to them, but doing so, they are also&nbsp;leaving behind wines and spirits. The latest quarter shows that Constellation continues to benefit from premium prices. While the industry continues being cautious in an uncertain macroeconomic environment, Constellation&rsquo;s beers were the biggest gainers for the twelfth successive quarter.
Yet, demand for spirits continues to fall.&nbsp;
But CEO Bill Newlands admitted the challenging macroeconomic backdrop has weighed on demand for beverage alcohol. Constellation gudied for full-year net sales growth between 4% and 6%, while expecting beer sales to go up from 6% to 8% and wine and spirits sales dropping 4% to 6%.
On the other hand, the wner of Guiness and Johnnie Walker, Diageo, is optimistic about spirits growth returning in the future. Diageo CEO Debra Crew believes that alcohol sales growth will return with the improving consumer environment. There&rsquo;s also increasing support from A list celebrities who are lending their influence to liquor brands. Among celebrities helping liquor brands become big businesses are Matthew McConaghew launched an organic tequilla brand, while Ryan Reynlods became a co-owner of Aviation Gin that was scooped up by Diageo in 2020, with George Clooney leading the way back in 2013 by co-founding Casamigos Tequilla, that was also sold to Diageo. But the reality is that Diageo plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>) posted bleak quarterly results in September, reflecting a weak macroenvironment in North America. After another lacluster quarter for wine and spirits, Constellation is expecting a &lsquo;sequential&rsquo; improvement over the second half of fiscal 2025.&nbsp;
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Constellation Brands' Latest Quarter Shows Wine And Spirits Business Continue To Fall From Glory

A marketing company that counts actor Ryan Reynolds as its chief creative officer plans to go public in 2025, adding to the recent success stories for the actor best known for playing "Deadpool"<a href="https://www.benzinga.com/general/entertainment/24/09/40737439/ryan-reynolds-dominates-box-office-as-deadpool-while-also-building-billion-dollar-businesse"> on the big screen.</a>
What Happened: Connected TV advertising company MNTN, is the owner of the <a href="https://www.benzinga.com/general/entertainment/23/07/33427835/ryan-reynolds-is-bringing-a-popular-television-alien-back-to-screens-hide-your-cats">Maximum Effort marketing segment</a> co-founded by Reynolds and George Dewey in 2018.
Known best for its advertisements to promote "Deadpool" and other viral advertisements for companies connected to Reynolds, Maximum Effort Marketing was bought out by MNTN in 2021.
MNTN is eyeing a 2025 IPO according to a new report from <a href="https://www.bloomberg.com/news/articles/2024-09-27/ryan-reynolds-s-mntn-is-said-to-tap-morgan-stanley-for-2025-ipo?sref=TBDibEcD">Bloomberg</a>, with Morgan Stanley set to work on the public offering.
The connected TV advertising company raised $119 million in a Series D round in 2021 with BlackRock Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) and Fidelity Management leading the round with $110 million invested together.
The Maximum Effort name comes from a catchphrase of Reynolds' Deadpool character. A separate Maximum Effort Productions company was not included in the sale to MNTN and is not part of the IPO. Dewey serves as the chief brand officer at Maximum Effort Marketing.
The marketing company from Reynolds has made ads for companies like Aviation Gin and Mint Mobile, which are connected to the actor. The company also made a well-known ad for dating company Match.com that <a href="https://www.youtube.com/watch?v=KABSYzPqTTg">featured </a>Satan and marked the debut of Taylor Swift's re-recording of the hit song "Love Story."
"I genuinely love marketing and I have been gobsmacked by how much fun it has been and how fast we have grown. We wanted a future for our marketing arm that ensured we could continue to move fast, have fun and do really rewarding work," Reynolds said at the time of MNTN's acquisition.
Reynolds said MNTN's simplicity, speech and ability to open up access to TV for advertisers who can't pay for upfront agreements stood out.
"I believe the combination of our companies will create a 1+1 equals 3 situation, assuming my math checks out," Reynolds added at the time.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: In a world of connected TV and viral advertisements that have to be quick and catchy, MNTN could stand out in a crowded field. The company's involvement in Reynolds and connection to several of his companies and movies could also help power growth in the coming years.
Aside from Maximum Effort Marketing and MNTN, Reynolds has built up several companies that are part of his success story away from the big screen.
The actor was a <a href="https://www.benzinga.com/m-a/23/03/31362824/ryan-reynolds-mobile-company-gets-1-35b-buyout-from-t-mobile-will-he-purchase-an-nhl-team-with-that">co-owner in Mint Mobile, </a>which was sold to T-Mobile US Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NYSE">TMUS</a>) at a $1.35 billion valuation. Reynolds had a stake in Aviation Gian, which was sold to Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) for $610 million in 2020.
Reynolds is also a<a href="https://www.benzinga.com/general/entertainment/24/04/38530584/ryan-reynolds-rob-mcelhenney-buy-another-soccer-team-can-dynamic-duo-turn-around-mexico-clu"> co-owner in soccer team</a> Wrexham AFC, owns a stake in Mexican soccer team Necaxa, and owns a stake in a Liberty Media Corporation Formula 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) racing team. The actor was also among the previously interested parties in buying the Ottawa Senators NHL team.
While it is unknown if Reynolds owns a stake in MNTN, the IPO likely comes thanks in part to the success of Maximum Effort Marketing in recent years. The IPO could further illustrate the success Reynolds has had outside of acting.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Shutterstock

Entertainment

IPOs

FWONA

FWONK

TMUS

Ryan Reynolds' Billion-Dollar Streak: Will His Viral Marketing Firm Go Public Next?

<a href="https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof" title="https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof">https://www.diageo.com/en/news-and-media/press-releases/2024/diageo-expands-leading-position-in-non-alc-spirits-with-acquisition-of-ritual-zero-proof</a>

Diageo North America Acquires Ritual Zero Proof Non-Alcoholic Spirits; Deal Has Been Funded Through Existing Cash Resources; Exact Financial Terms Not Disclosed

Actor Ryan Reynolds is best-known these days for his role as Deadpool on the big screen, a role that is setting records for media giant The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a third franchise film <a href="https://www.benzinga.com/general/entertainment/24/07/40003208/ryan-reynolds-hugh-jackman-starrer-deadpool-wolverine-breaks-box-office-records-rakes-in-ov">currently in theaters. </a>
&#8220;Deadpool &amp; Wolverine&#8221; has grossed $582.7 million domestically and $634.8 billion internationally for a global total of $1.22 billion at the time of writing.
The film has set many records, including several for an &#8220;R&#8221; rated film, along with boosting Disney&#8217;s box office success for the 2024 year. 
While he&#8217;s known for his role as Deadpool, aka the &#8220;merc with the mouth,&#8221; Reynolds is also known for his investing and entrepreneurship thanks to a series of billion-dollar companies. 
Building Companies:&nbsp;A thread on X, formerly known as Twitter, about&nbsp;<a href="https://www.benzinga.com/topic/ryan-reynolds" target="_blank" rel="noreferrer noopener">Ryan Reynolds</a>&nbsp;highlights that he may be the &#8220;GOD of billion dollar brands.&#8221;
The&nbsp;<a href="https://twitter.com/timjcarden/status/1772277477424971807?s=20" target="_blank" rel="noreferrer noopener">thread&nbsp;</a>by Tim Carden has over five million views and points to several commonalities among the companies that are owned or were sold by Reynolds.
Carden said Reynolds looks for opportunities and when he makes an investment or deal he actively markets the business himself and oftentimes &#8220;becomes the face of the brand.&#8221; Reynolds also helps in the creative process of making ads about products.
&#8220;When Ryan sees a viable opportunity, he takes it,&#8221; Carden said.
An example is&nbsp;Aviation Gin,&nbsp;which Reynolds tasted and fell in love. His love for the brand led to an investment and the actor became the face of the brand. Aviation Gin was later sold to alcohol giant&nbsp;Diageo PLC&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>), netting a nice return for the actor.
&#8220;While many celebrities just pump money and sit back, Ryan is in the driver&#8217;s seat.&#8221;
Another example highlighted by Carden is the marketing company&nbsp;Maximum Effort, which has helped with ads for the Deadpool movies, which the company is co-producing with Disney. 
&#8220;Ryan knows that as an actor, his strengths are in front of a camera — and he plays to his strengths.&#8221;
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent083024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It&#8217;s Important: Carden said Reynolds knows how to perfectly capitalize on trends and use his talents after recognizing the trend.
Reynolds<a href="https://www.benzinga.com/general/entertainment/24/01/36875148/formula-one-rejects-andretti-general-motors-team-bid-what-this-could-mean-for-us-growth-esp" target="_blank" rel="noreferrer noopener">&nbsp;also invested in&nbsp;</a>a&nbsp;Liberty Media Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) Formula 1&nbsp;motor racing team, which comes as the valuation of teams in the sport is rising.
The actor also owns a soccer team and was&nbsp;<a href="https://www.benzinga.com/general/entertainment/23/05/32174242/ryan-reynolds-senators-bid-may-be-dropped-like-its-hot-as-snoop-steps-up-in-next-episode-of" target="_blank" rel="noreferrer noopener">among the bidders</a>&nbsp;for the National Hockey League&#8217;s Ottawa Senators.
&#8220;Ryan Reynolds is more than just an actor. He is also a savvy serial businessman who knows a thing or two about building a billion-dollar brand. He hunts for opportunities, gets personally involved in marketing the business, injects his personal brand, and is always on the move,&#8221; Carden said.
Along with Aviation Gin getting bought out, another Reynolds investment recently saw a buyout.&nbsp;Mint Mobile&nbsp;was purchased by&nbsp;T-Mobile US&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>).
Like Aviation Gin, Reynolds starred in ads for the company after he invested.
The ownership of Maximum Effort helps Reynolds quickly make ads for companies he invests in and for movies he stars in. The combination leads to Reynolds easily recognizable as an investor or the face of a product.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent083024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Education

Entrepreneurship

Success Stories

Ryan Reynolds Dominates Box Office As Deadpool While Also Building Billion Dollar Businesses

Investors interested in Beverages - Alcohol stocks are likely familiar with Kirin Holdings Co. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/knbwy#OTC">KNBWY</a>)&nbsp;and Diageo (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>). But which of these two stocks is more attractive to value investors? We&#39;ll need to take a closer look to find out.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Kirin Holdings Co. and Diageo are sporting Zacks Ranks of #2 (Buy) and #5 (Strong Sell), respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that KNBWY has an improving earnings outlook. But this is only part of the picture for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
KNBWY currently has a forward P/E ratio of 13.61, while DEO has a forward P/E of 18.93. We also note that KNBWY has a PEG ratio of 0.77. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company&#39;s expected EPS growth rate. DEO currently has a PEG ratio of 4.01.
Another notable valuation metric for KNBWY is its P/B ratio of 1.32. The P/B is a method of comparing a stock&#39;s market value to its book value, which is defined as total assets minus total liabilities. By comparison, DEO has a P/B of 6.19.
These metrics, and several others, help KNBWY earn a Value grade of B, while DEO has been given a Value grade of D.
KNBWY stands above DEO thanks to its solid earnings outlook, and based on these valuation figures, we also feel that KNBWY is the superior value option right now.
<a href="https://www.zacks.com/stock/news/2328403/knbwy-or-deo-which-is-the-better-value-stock-right-now?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_3-2328403">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Analyst Ratings

KNBWY

KNBWY or DEO: Which Is the Better Value Stock Right Now?

Shares of Merck &amp; Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS <a href="https://www.benzinga.com/general/biotech/24/07/40036607/mercks-q2-earnings-revenue-and-eps-beat-helped-by-strong-keytruda-sales-but-acquisition-costs-bit">guidance below estimates</a>.
Merck reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Merck shares dipped 9.5% to $115.50 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) shares jumped 147.8% to $2.9250 after the company announced topline results from its Phase 2 OVATION 2 study with IMNN-001. The results showed an 11.1-month improvement in median overall survival compared to standard-of-care alone in the intent-to-treat population.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) surged 97% to $0.1731. AGAPE ATP strengthened wellness division via innovative incubation with emerging local SMEs.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares climbed 53% to $2.60 after the company announced FDA clearance of its IND application for a Phase 2 clinical trial of NGC-Cap in breast cancer.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) gained 33% to $1.1513.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares gained 29% to $0.3850.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) jumped 28% to $3.4018.</li>
<li>CalciMedica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) jumped 26.3% to $5.24.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) rose 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) rose 19.1% to $2.3050.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) gained 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) climbed 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Meta Data Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) gained 18.8% to $5.42.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 18.3% to $0.59 after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 18.3% to $6.20 after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) gained 16.1% to $17.00 following upbeat earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) gained 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) climbed 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) gained 13.4% to $156.48 following -quarter earnings.</li>
<li>Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) climbed 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) gained 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) climbed 8.5% to $63.98 after the company reported better-than-expected second quarter financial results.</li>
<li>Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) rose 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) gained 6.4% to $500.83 following better-than-expected quarterly earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 80.8% to $11.44. This sudden decline was triggered by the registration of two private placements with the U.S. Securities and Exchange Commission, which unlocked millions of shares and led to increased selling pressure, Bloomberg reported on Tuesday.</li>
<li>VBI Vaccines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBIV#NASDAQ">VBIV</a>) declined 64.8% to $0.1960 after the company was granted protection under Canada&#8217;s CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst &amp; Young was appointed as the monitor during the restructuring process.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) dipped 40.8% to $0.6158 after the company announced it entered into an exclusive license agreement with Cortice Biosciences.</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) tumbled 37% to $0.73.</li>
<li>Bloomz Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) dipped 30.7% to $1.78.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) fell 26.6% to $1.0901 after the company reported worse-than-expected quarterly sales results.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 25.2% to $12.27 after declining 4% on Monday.</li>
<li>VSee Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) fell 23.3% to $2.7999.</li>
<li>SmartRent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) dipped 21.5% to $1.8850 after the company announced a CEO resignation and suspended its 2024 outlook.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares fell 21.1% to $28.13 after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 16.5% to $152.91 after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) fell 16.2% to $13.82. NIP Group announced the closing of its initial public offering and partial exercise of underwriters' option to purchase additional ADSs.</li>
<li>Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) dipped 16.2% to $43.68 after the company reported worse-than-expected quarterly financial results. Additionally, Raymond James downgraded the stock.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 14.2% to $32.24 after the company issued roughly in-line guidance.</li>
<li>OneWater Marine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) dipped 13.2% to $26.43 after the company reported worse-than-expected third-quarter financial results and issued weak guidance.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 11.6% to $37.06 after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Transcat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) declined 11.2% to $120.00 following weak quarterly sales.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) dipped 9.7% to $233.65 following reports indicating Delta Air Lines would seek compensation from the cybersecurity company for last week&#8217;s outage.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 9.3% to $50.61 following weak quarterly sales.</li>
<li>Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) fell 8.7% to $38.99 following second-quarter results.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 8.3% to $50.40 after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) declined 6.7% to $231.31 after the company reported worse-than-expected second-quarter sales results.</li>
<li>The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) fell 6.2% to $159.37 following a quarterly revenue miss.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 5.5% to $124.30 after the company missed annual profit expectations.</li>
<li>Fresenius Medical Care AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) shares declined 4.5% to $19.45 following weak quarterly sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40039797/top-3-health-care-stocks-you-may-want-to-dump-this-quarter">Top 3 Health Care Stocks You May Want To Dump This Quarter</a></li>
</ul>

Intraday Update

AMKR

ATPC

BIMI

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

JTAI

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PHAR

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VRNS

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Shares of Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak <a href="https://www.benzinga.com/news/earnings/24/07/40022763/lattice-semiconductor-stock-falls-on-worse-than-expected-q2-results">third-quarter revenue guidance</a>.
Lattice Semiconductor reported quarterly earnings of 23 cents per share, which missed the analyst consensus estimate of 24 cents per share. Quarterly sales came in at $124.076 million, which missed the analyst consensus estimate of $130.172 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Lattice Semiconductor shares tumbled 14.8% to $46.82 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares dipped 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) declined 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares dipped 9.6% to $14.85 in pre-market trading after declining 4% on Monday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares tumbled 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) declined 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares fell 7.8% to $51.50 in pre-market trading following weak quarterly sales.</li>
<li>Soho House &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) fell 7.3% to $4.80 in pre-market trading. Soho House &amp; Co will release its second-quarter financial results on Friday, Aug. 9.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) declined 6.8% to $14.67 in pre-market trading.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.</li>
<li>Fresenius Medical Care AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) shares declined 5.7% to $19.20 in pre-market trading following weak quarterly sales.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares declined 4.7% to $246.69 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009447/roblox-morgan-stanley-and-2-other-stocks-insiders-are-selling">Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

FTEL

SHCO

Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Shares of F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings <a href="https://www.benzinga.com/news/earnings/24/07/40023356/f5-shares-climb-on-better-than-expected-q3-results-strong-forward-guidance">guidance above estimates</a>.
F5 reported quarterly earnings of $3.36 per share, which beat the analyst consensus estimate of $2.97 per share. Quarterly sales came in at $695.495 million, which beat the analyst consensus estimate of $686.062 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
F5 shares jumped 14.3% to $202.92 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) gained 104.2% to $2.41 in pre-market trading. IMUNON will report topline results from the Phase 2 OVATION 2 study with IMNN-001 In advanced ovarian cancer on July 30.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares climbed 48% to $0.4422 in pre-market trading.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 26.3% to $0.6289 in pre-market trading after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 22.3% to $6.41 in pre-market trading after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 17.4% to $99.50 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) gained 16.1% to $22.51 in pre-market trading after jumping 47% on Monday.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares gained 15.2% to $19.00 in pre-market trading. NIP Group announced the closing of its initial public offering and partial exercise of underwriters&#8217; option to purchase additional ADSs.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 10.1% to $8.30 in pre-market trading. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>Nomura Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) gained 8.2% to $6.33 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 79.9% to $12.00 in pre-market trading after dipping 23% on Monday.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares declined 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 14.8% to $46.82 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>TROOPS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares fell 13.2% to $3.22  in pre-market trading.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 9.6% to $14.85 in pre-market trading after declining 4% on Monday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 7.8% to $51.50 in pre-market trading following weak quarterly sales.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009447/roblox-morgan-stanley-and-2-other-stocks-insiders-are-selling">Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

SERV

TROO

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Diageo plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) famed for its Johnnie Walker whisky and Tanqueray gin, is bracing for its first yearly sales decline since 2020. The company has been under the radar following a profit warning last November, leading to a dip in investor confidence.
What Happened: Diageo&#8217;s U.S. market share has seen a downward trend. Analysts are predicting a 0.2% fall in net sales for the year ending June 30. The previous year&#8217;s net sales of Diageo were 17.1 billion pounds ($22 billion), Reuters reported on Monday.
Despite achieving almost 11 billion pounds ($14.13 billion) in sales during the first half of the year, analysts like Fintan Ryan at Goodbody Stockbrokers caution that the final result could be worse than consensus forecasts. Persistent issues in the U.S. and Latin America could result in a lower full-year delivery, Ryan noted.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39997974/anthony-scaramucci-tim-scott-weigh-in-ahead-of-ex-presidents-address-at-bitcoin-2024-confe?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Anthony Scaramucci, Tim Scott Weigh In Ahead Of Ex-President&#8217;s Address At Bitcoin 2024 Conference: &#8216;Trump&#8217;s Move To Court Bitcoin And Towards Crypto Assets Has Shaken The Democrats At Core&#8217;</a>
Diageo&#8217;s recent struggles mirror the broader challenges the spirits industry is facing, as demand has dropped following a post-pandemic sales boom. Investors are eager to see Diageo reclaim its market share in North America, which contributes to 40% of its sales.
Moreover, Diageo has cautioned of a potential 10-20% sales drop in Latin America and the Caribbean. The company was taken by surprise by the build-up of unsold stock among wholesalers and retailers in Mexico during the first half of the year.
Why It Matters: Earlier this year, Diageo&#8217;s shares took a hit, <a href="https://www.benzinga.com/markets/equities/24/01/36840057/johnnie-walker-maker-diageo-tanks-after-missing-estimates-latin-america-woes-deepen">dropping over 3%</a> after the company reported a decline in organic net sales, missing analyst estimates. The spirits giant also warned of further challenges in Latin America, where unsold stock accumulates.
Adding to the company&#8217;s woes, American rapper Sean "Diddy" Combs and Diageo ended their <a href="https://www.benzinga.com/general/entertainment/24/01/36657562/rapper-diddy-and-diageo-part-ways-a-look-at-the-high-stakes-split-in-the-beverage-industry">long-standing partnership</a> on Cîroc vodka and DeLeón tequila earlier this year. The split followed a legal dispute in which Combs sued Diageo, alleging the company neglected the DeLeón brand in favor of its other tequila labels.
Price Action: Diageo closed at $132.43 on Friday, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39970069/investors-go-all-in-on-small-caps-pour-over-6-billion-into-russell-2000-etf-this-month-they-will?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Investors Go All In On Small Caps, Pour Over $6 Billion Into Russell 2000 ETF This Month: They &#8216;Will Return To Larger-Cap Alternatives,&#8217; Veteran Analyst Says</a></li>
</ul>
Image by pil76 via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Equities

Johnnie Walker Maker Diageo Faces First Annual Sales Decline Since 2020 Amid Investor Concerns And Profit Warning

Legal

New Delhi City Police Summons Diageo India CEO To Appear At Investigation Into Case Linked To Payments By Government Agencies For Liquor Purchases

Labour Party member Keir Starmer is set to become the new prime minister of the United Kingdom with <a href="https://www.benzinga.com/news/24/07/39640147/keir-starmer-to-become-uk-prime-minister-as-labour-wins-big-over-rishi-sunaks-conservatives-mohamed">a win over the Rishi Sunak-led Conservative Party.</a>
The win marks an end to 14 years of Conservative Party control in the United Kingdom. The Labour Party will also have one of the largest majority government leads in the country in 25 years, as reported by CNN.
"A mandate like this comes with a great responsibility," Starmer said Friday. 
Starmer promised to put "country first, party second" in his victory speech.
UK Stocks &amp; ETFS: Gains for United Kingdom stocks and ETFs were minimal on Friday with the results of the election potentially priced in and others dissecting what the Labour Party in control means for certain sectors.
The iShares MSCI United Kingdom ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWU#NYSE">EWU</a>) is up 0.5% on Friday. The largest U.K. ETF has $2.8 billion in assets under management and holds 80 stocks representing <a href="https://www.benzinga.com/quote/EWU/news">the largest companies in the country</a>.
The top holdings are:
AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>)
Shell PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>)
HSBC Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBC#NYSE">HSBC</a>)
Unilever PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>)
BP PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>)
RELX PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RELX#NYSE">RELX</a>)
GlaxoSmithKline PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>)
Rio Tinto PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>)
Diageo PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>)
Glencore PLC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GLNCY#OTC">GLNCY</a>)
Eight of the 10 largest holdings are up Friday at the time of writing, with HSBC and Rio Tinto trading lower.
The top weightings in the iShares ETF are the categories of financials (19.3%), consumer staples (16.4%) and energy (13.4%).
The Franklin FTSE United Kingdom ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLGB#NYSE">FLGB</a>) also offers exposure to the country with 107 holdings. The fund has all the same top 10 holdings as the iShares MSCI United Kingdom ETF, in a slightly different order and at smaller weightings. The ETF's largest categories are financials (19.5%), consumer staples (15.5%) and energy (14.4%).
Another ETF option is the iShares MSCI United Kingdom Small Cap ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/EWUS#BATS">EWUS</a>). The ETF holds 231 stocks and has smaller weightings for the small-cap components it holds. The top categories for the ETF are industrials (21.5%), financials (19.8%) and consumer discretionary (14.8%).
What Experts Are Saying: British private bank and wealth management company Coutts sees policy changes from the Labour Party leadership taking time to materialize.
"In terms of what this means for the U.K. population and our clients, we will closely monitor the developments of a Keir Starmer government and its potential impact on markets," Coutts Chief Investment Officer Fahad Kamal said.
Kamal said history shows U.K. elections don't tend to have a "long-term impact on markets."
The CIO said it could be "business as usual" for the United Kingdom. One item to closely monitor is falling inflation in the country and the potential for rate cuts soon, which could improve economic growth in the country, he said. 
RBC Capital analysts see the homebuilding sector in the United Kingdom benefitting with a Labour Party win, as reported by CNBC. The analysts said the new leadership and policy pledges could lead to a "new age" for homebuilding in the country.
"Over the last few years housebuilders' potential has been hamstrung, but over the next few this potential is likely to be unleashed," the RBC analysts said.
It is worth noting the iShares MSCI United Kingdom Small Cap ETF counts the real estate sector as its fourth-largest weighting at 12.3%, which could make the ETF stand out based on policy. The EWU and FLGB ETFs have 0.8% and 1.1% exposure to the real estate sector, respectively.
Allianz also sees opportunity in U.K. homebuilders with the Labour Party win and likely cuts to interest rates ahead. 
"We expect rules and regulations around planning permissions to be quickly relaxed by the incoming government," Allianz said.
Allianz also sees opportunity in U.K.-listed mining companies thanks to the electrification of the energy supply.
Citi has a preference for the FTSE 250 over the FTSE 100, preferring small to mid-cap sized companies over large caps, as reported by Investing.com.
"We see an improving balance of risks for UK SMID caps, which have underperformed, but are expected to have superior growth vs. large caps. SMID caps are also better positioned to benefit from rate cuts and a pick-up in dealmaking," Citi said.
Sectors like real estate and utilities were mentioned positively by Citi in the post-election comments.
Related Link:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39636949/british-pound-european-stocks-surge-ahead-of-uk-election-results-bitcoin-plummets-w">British Pound, European Stocks Surge Ahead Of UK Election Results; Bitcoin Plummets: What&#8217;s Driving Markets Thursday?</a></li>
</ul>
Photo via Shutterstock.

Specialty ETFs

Global

ETFs

EWUS

FLGB

GLNCY

HSBC

RELX

SHEL

United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win

Citigroup analyst Simon Hales upgrades Diageo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) from Neutral to Buy.

Upgrades

Citigroup Upgrades Diageo to Buy

Diageo plc&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>) focus on improving productivity coupled with its diversified footprint, a solid portfolio of brands, innovation and marketing investments, and pricing initiatives, appear encouraging. In the latest development, the company revealed that it has established a model for Guinness in Nigeria by entering into a long-term partnership with a leading manufacturing, marketing and distribution conglomerate, Tolaram, to drive growth and sell its shareholding in Guinness Nigeria PLC. This transaction is likely to conclude in fiscal 2025, subject to the satisfaction of a few conditions, including the regulatory approvals in Nigeria.
<h3>Details of the Alliance</h3>
Per the terms of this alliance, Tolaram will buy Diageo&#39;s 58.02% shareholding in Guinness Nigeria PLC, which is listed on the Nigerian Stock Exchange, for a share price of 81.60 NGN per share. Boasting a 50-year presence in Nigeria, Tolaram has extensive operations in the region and is quite a popular consumer packaged goods company. 
However, Diageo will retain the ownership of the Guinness brand, which will be licensed to Guinness Nigeria for the long term, thereby empowering its growth and development in the country under Tolaram&#39;s stewardship. The company will also remain in the country via its completely owned international premium spirits business to cater to a wider geographic reach in West Africa, with Nigeria being among the key operational hub. After the completion of this transaction, Guinness Nigeria will remain listed on the Nigerian Stock Exchange while Tolaram plans to launch a mandatory takeover offer in compliance with the local law requirements.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/29/68785.jpg?v=1146961652" /> 
Image Source: Zacks Investment Research
Notably, the aforesaid transaction is consistent with Diageo&#39;s asset-light beer operating model. This model enables the selection of the most suitable structure and route to market for Guinness while retaining ownership of the iconic Guinness brand. The company will continue driving the brand and marketing strategy of Guinness in Nigeria. 
This new structure for Nigeria further emphasizes Diageo&#39;s active portfolio management and development of an efficient operating model in West Africa to deliver sustainable growth. We note that the aforesaid transaction follows its announcement in October 2023 of a fully-owned spirits company.
<h3>How is Diageo Poised?</h3>
Diageo is progressing well in its new productivity commitment to deliver $2 billion of productivity savings over the three years from fiscal 2025 to fiscal 2027. This Zacks Rank #3 (Hold) company expects to deliver this accelerated productivity commitment across the cost of goods, marketing spending and overheads. It plans to support this acceleration through investments, including its supply-chain agility program announced in July 2022. 
However, the company has been witnessing soft trends in its operations in Latin America and the Caribbean, which contributes 10% to its net sales. The fast-changing consumer sentiment and high inventory levels have been significantly impacting the total business performance in the LAC region. Year to date, Diageo&#39;s shares have lost 7.5% compared with the industry&#39;s 10.8% decline.
<h3>Stocks to Consider</h3>
Vital Farms Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vitl#NASDAQ">VITL</a>) offers a range of produced pasture-raised foods. It currently sports a Zacks Rank #1 (Strong Buy). VITL has a trailing four-quarter average earnings surprise of 102.1%. 
The Zacks Consensus Estimate for Vital Farms&#39; current financial-year sales and earnings per share indicates growth of 22.5% and 59.3%, respectively, from the year-ago reported numbers. 
Freshpet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frpt#NASDAQ">FRPT</a>), which is a pet food company, currently sports a Zacks Rank of 1. FRPT has a trailing four-quarter earnings surprise of 118.2%, on average. 
The consensus estimate for Freshpet&#39;s current fiscal year sales and EPS indicates growth of 24.8% and 177.1%, respectively, from the year-ago reported numbers. 
Utz Brands Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/utz#NYSE">UTZ</a>), which manufactures a diverse portfolio of salty snacks, currently carries a Zacks Rank #2 (Buy). UTZ has a trailing four-quarter earnings surprise of 2%, on average. 
The Zacks Consensus Estimate for Utz Brands&#39; current financial-year EPS indicates growth of 26.3% from the year-ago reported numbers.
<a href="https://www.zacks.com/stock/news/2287949/diageo-deo-tolaram-alliance-to-aid-growth-in-guinness-nigeria?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2287949">To read this article on Zacks.com click here.</a>

Small Cap

FRPT

VITL

Diageo, Tolaram Alliance to Aid Growth in Guinness Nigeria

Coca-Cola Europacific Partners (CCEP) today announces the resignation of Nik Jhangiani, SVP and Chief Financial Officer (CFO) with a search for his successor well underway,
Diageo plc &nbsp;announces that Nik Jhangiani will join the company as Chief Financial Officer, taking up the position and joining Diageo&#39;s Board and Executive Committee in Autumn 2024. Lavanya Chandrashekar will step down from the Executive Committee and Board at the same time after three years as Chief Financial Officer and six years with the company, and will return to the US.

Management

Coca-Cola European Partners plc Ordinary Shares

CCEP

Coca-Cola Europacific Partners CFO Nik Jhangiani Steps Down, Set To Join Diageo As CFO

Alcohol companies could face a challenge with younger consumers after Surgeon General warning

Bank of America Securities analyst Andrea Pistacchi reiterated a Buy rating on Diageo (DGEAF – Research Report) today and set a price target of p2,...

Diageo's Growth Driven by Strong North American and Latin American Performance Surpasses Consensus Estimates

UBS analyst Sanjeet Aujla maintained a Buy rating on Diageo (DGEAF – Research Report) today and set a price target of £29.20. The company's shares ...

Diageo (DGEAF) Receives a Buy from UBS

In a report released today, Ed Mundy from Jefferies maintained a Buy rating on Diageo (DGEAF – Research Report), with a price target of £28.00. The...

Jefferies Reaffirms Their Buy Rating on Diageo (DGEAF)

In a report released today, Laurence Whyatt from Barclays maintained a Buy rating on Diageo (DGEAF – Research Report), with a price target of £28.6...

Diageo (DGEAF) Receives a Buy from Barclays

Deutsche Bank analyst Mitch Collett maintained a Sell rating on Diageo (DGEAF – Research Report) today and set a price target of £20.20. The compan...

Diageo (DGEAF) Gets a Sell from Deutsche Bank

In a report released today, Celine Pannuti CFA from J.P. Morgan maintained a Hold rating on Diageo (DGEAF – Research Report), with a price target o...

J.P. Morgan Remains a Hold on Diageo (DGEAF)

ClearBridge Dividend Strategy Q4 2024 Commentary

Deutsche Bank raised the firm's price target on Diageo (DEO) to 2,020 GBp from 1,970 GBp and keeps a Sell rating on the shares. Published first on ...

Diageo price target raised to 2,020 GBp from 1,970 GBp at Deutsche Bank

Barclays lowered the firm's price target on Diageo (DEO) to 2,860 GBp from 2,900 GBp and keeps an Overweight rating on the shares. Published first ...

Diageo price target lowered to 2,860 GBp from 2,900 GBp at Barclays

AAPL

ABEV

ALTO

APOS

AVGO

CABGY

CMCSA

DGEAF

HEINY

HLNCF

KVUE

MDLZ

MGPI

MSFT

NSRGF

NSRGY

NVDA

SNDL

UNLYF

VINE

VWESQ

Press Releases

Diageo, MADD, the NFL and Uber Team Up to Launch "Take a Minute. Make a Plan." Campaign to Tackle Impaired Driving

'TIS THE SEASON: SMIRNOFF AND SAWEETIE UNWRAP A FESTIVE  POP-UP IN NYC CURATED FOR ALL YOUR GIFTING NEEDS

JOHNNIE WALKER ANNOUNCES CANADIAN LAUNCH OF NEW APRES-SKI INSPIRED RARE WHISKY WITH JOHNNIE WALKER BLUE LABEL ICE CHALET

GUINNESS BRINGS HOLIDAY MAGIC TO MONTREAL WITH ITS "WORLD OF GUINNESS" POP-UP EXPERIENCE

Buchanan's Scotch Whisky Pledges $150,000 From its 200% Futuro Fund to Create Más Noches Buenas for 200% Foodservice Workers This Holiday Season

IT'S THE MOST WONDERFUL PINT OF THE YEAR

/C O R R E C T I O N -- Smirnoff/

CÎROC Champions Creative Ease with the 'Blue Dot Creative Residency': An Innovative Program Empowering Emerging Storytellers

TANQUERAY LONDON DRY GIN LAUNCHES 'CLASSIC OR NOTHING' CAMPAIGN: A BOLD DECLARATION THAT CELEBRATES THE ENDURING INFLUENCE OF TIME-HONORED CLASSICS AND THE LEGENDS THAT CHOOSE THEM

CROWN ROYAL UNVEILS GAME PLAN TO HONOUR CANADA'S UNSUNG HOCKEY BEAUTIES WITH NEW CUJO CAMPAIGN AND YEAR-LONG BARDOWN POWER PLAY

Comments

Diageo

空売り

Diageo (NYSE:DEO) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル